Universität zu Köln

Choi, Yeong-Hoon, Nasseri, Boris and Stamm, Christof (2011). Cardiac Cell Therapy and Bypass Surgery. Curr. Pharm. Design, 17 (30). S. 3348 - 3356. SHARJAH: BENTHAM SCIENCE PUBL LTD. ISSN 1873-4286

Full text not available from this repository.

Abstract

More than 10 years ago, the first clinical application of cardiac cell therapy was performed in a patient undergoing coronary bypass grafting (CABG). Ever since, catheter-based cell delivery approaches have dominated the field, but surgical cell therapy continues to provide important information on safety and efficacy of various cell therapy strategies. The open chest offers unrivalled simplicity and precision of intramyocardial cell injection, and the cardiac surgical patient population includes those with very advanced heart disease who are in greatest need of innovative regeneration concepts. In this review, the clinical experience with cardiac surgical cell therapy is summarized and critically appraised.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Choi, Yeong-Hoon UNSPECIFIED UNSPECIFIED UNSPECIFIED Nasseri, Boris UNSPECIFIED UNSPECIFIED UNSPECIFIED Stamm, Christof UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-487490
DOI:	10.2174/138161211797904145
Journal or Publication Title:	Curr. Pharm. Design
Volume:	17
Number:	30
Page Range:	S. 3348 - 3356
Date:	2011
Publisher:	BENTHAM SCIENCE PUBL LTD
Place of Publication:	SHARJAH
ISSN:	1873-4286
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language BONE-MARROW-CELLS; ISCHEMIC-HEART-DISEASE; MYOBLAST TRANSPLANTATION; INTRAMYOCARDIAL DELIVERY; MYOCARDIAL REGENERATION; STEM-CELLS; AUTOLOGOUS TRANSPLANTATION; SCARRED MYOCARDIUM; SURGICAL-TREATMENT; CONTROLLED-TRIAL Multiple languages Pharmacology & Pharmacy Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/48749